THRN vs. HRTS
Compare and contrast key facts about Thorne HealthTech, Inc. (THRN) and Tema Obesity & Cardiometabolic ETF (HRTS).
HRTS is an actively managed fund by Tema. It was launched on Nov 20, 2023.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: THRN or HRTS.
Key characteristics
| THRN | HRTS |
|---|
Correlation
The correlation between THRN and HRTS is 0.00. This indicates that the assets' prices tend to move in opposite directions. Negative correlation can be particularly beneficial for diversification and risk management, as one asset may offset the losses of the other during market fluctuations.
Performance
THRN vs. HRTS - Performance Comparison
The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
THRN vs. HRTS - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Thorne HealthTech, Inc. (THRN) and Tema Obesity & Cardiometabolic ETF (HRTS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Not enough dataDividends
THRN vs. HRTS - Dividend Comparison
Neither THRN nor HRTS has paid dividends to shareholders.
Drawdowns
THRN vs. HRTS - Drawdown Comparison
Volatility
THRN vs. HRTS - Volatility Comparison
The current volatility for Thorne HealthTech, Inc. (THRN) is 0.00%, while Tema Obesity & Cardiometabolic ETF (HRTS) has a volatility of 4.51%. This indicates that THRN experiences smaller price fluctuations and is considered to be less risky than HRTS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.